Additional information

Size	10cm x 10cm

Features

FEATURES	BENEFITS
Proven efficacy	Clinical best practice
Incorporates NOSF technology	Reduces proliferation of MMPs
Incorporates TLC technology	Creates a moist wound environment Non-adherent Atraumatic removal
Flexible and conformable	Assists in good fit on all wound shapes Suitable for deep and cavity wounds
Non-woven substrate	Can be cut Will not shed into the wound
Seven day wear time	Reduces need to change contact layer at time of secondary dressing change

Indication

Non to low exuding (a secondary absorbent dressing can be used for highly exuding wounds)
- Chronic wounds
- Diabetic foot ulcers
- Leg ulcers
- Pressure injuries
Long standing acute wounds
Wounds where surrounding skin is friable

UrgoStart^® Contact can be used in patients with leg ulcers, diabetic foot ulcers and pressure injuries, from whenever granulation tissue appears until complete healing. Leg ulcers, diabetic foot ulcers and pressure injuries take an average of 210 days to heal⁵. UrgoStart^® Contact reduces the healing time of these types of wounds by an average of 100 days⁴.

Contraindications

In order not to delay any optimal treatment, UrgoStart^® Contact is contraindicated in cancerous wounds and in fistula wounds which may reveal a deep abscess.
Do not use if there is a known sensitivity to UrgoStart^® Contact or its components.
Not suitable for use during hyperbaric treatment.

Instruction

UrgoStart^® Contact adheres to latex surgical gloves. It is therefore recommended that gloves be moistened with saline in order to make the handling easier. Clean the wound as per local protocol.
If antiseptic is first used, carefully rinse the wound with normal sterile saline before applying UrgoStart^® Contact
Dry the surrounding skin carefully
Remove the protective wings
Apply UrgoStart^® Contact to the wound
Cover UrgoStart^® Contact with a secondary dressing suitable to absorb the level of wound exudate and hold the secondary dressing in place with a conforming bandage, adhesive tape or an elasticated tubular bandage
For exuding wounds, use UrgoStart^® Foam Pad

UrgoStart^® Contact dressing may be changed every 2 to 4 days, and left in place for up to 7 days depending on the level of exudate and the wound condition. The recommended treatment duration for UrgoStart^® Contact is a minimum of 4 to 5 weeks.

Product Options

Product Code	Product Size	Units/Box
754127	10x10cm	10

Clinical Evidence

Meaume S, et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-Oligo Saccharide Factor wound dressing in the local management of venous leg ulcers. Wound Rep Reg. 2012; 20: 4, 500-511.
Edmonds M, Lazaro-Martinez JL, Alfayate-Garcia JM, Martinin J, Petit JM, Rayman G, Lovmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3)186-196.
Meaume S, Truchetet F, Cambazard F et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen. 2012;20:4, 500-511
Munter KC, Meaume S, Augustin M, Senet P, Kerijuel JC. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. J Wound care. 2017 Feb; 26 (sup2): S4-S15. Erratum in: J Wound Care. 2017 Mar 2; 26(3):153
Report to the French minister responsible for Social Security and the French Parliament concerning the evolution of French National Health Insurance charges and products for 2014. July 2013.